{
 "url": "https://etfiq.com/funds/fmed/holdings/",
 "section": "funds",
 "title": "FMED Holdings: All 68 Positions (May 31, 2026) | ETFIQ",
 "description": "All 68 FMED holdings with weights, as of May 31, 2026. The top 3 are UCB SA 4.73%, LFST 4.27% and DHR 3.42%. Download the full list as a CSV.",
 "as_of": "May 31, 2026",
 "ticker": "FMED",
 "fund": "Fidelity Disruptive Medicine ETF",
 "fund_page": "https://etfiq.com/funds/fmed",
 "positions": 68,
 "positions_listed_on_page": 68,
 "lead": "FMED held 68 positions as of May 31, 2026. UCB SA is the largest at 4.73%; the top 10 are 31.4% of the fund.",
 "source": {
  "name": "Form N-PORT filed with the SEC",
  "url": "https://www.sec.gov/Archives/edgar/data/945908/000003540226004621/primary_doc.xml",
  "document": "the fund’s SEC filing",
  "book_date": "2026-05-31",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "UCB SA",
   "ticker": null,
   "weight_pct": 4.732,
   "page": "https://etfiq.com/holdings/ucb/"
  },
  {
   "rank": 2,
   "holding": "LifeStance Health Group Inc",
   "ticker": "LFST",
   "weight_pct": 4.273,
   "page": "https://etfiq.com/holdings/lfst/"
  },
  {
   "rank": 3,
   "holding": "Danaher Corp",
   "ticker": "DHR",
   "weight_pct": 3.421,
   "page": "https://etfiq.com/holdings/dhr/"
  },
  {
   "rank": 4,
   "holding": "10X Genomics Inc",
   "ticker": "TXG",
   "weight_pct": 3.108,
   "page": "https://etfiq.com/holdings/txg/"
  },
  {
   "rank": 5,
   "holding": "Intuitive Surgical Inc",
   "ticker": "ISRG",
   "weight_pct": 2.918,
   "page": "https://etfiq.com/holdings/isrg/"
  },
  {
   "rank": 6,
   "holding": "Cogent Biosciences Inc",
   "ticker": "COGT",
   "weight_pct": 2.852,
   "page": "https://etfiq.com/holdings/cogt/"
  },
  {
   "rank": 7,
   "holding": "Alnylam Pharmaceuticals Inc",
   "ticker": "ALNY",
   "weight_pct": 2.794,
   "page": "https://etfiq.com/holdings/alny/"
  },
  {
   "rank": 8,
   "holding": "Argenx SE",
   "ticker": "ARGX",
   "weight_pct": 2.785,
   "page": "https://etfiq.com/holdings/argx/"
  },
  {
   "rank": 9,
   "holding": "Legend Biotech Corp",
   "ticker": "LEGN",
   "weight_pct": 2.294,
   "page": null
  },
  {
   "rank": 10,
   "holding": "UnitedHealth Group Inc",
   "ticker": "UNH",
   "weight_pct": 2.25,
   "page": "https://etfiq.com/holdings/unh/"
  },
  {
   "rank": 11,
   "holding": "Bio-Techne Corp",
   "ticker": "TECH",
   "weight_pct": 2.243,
   "page": "https://etfiq.com/holdings/tech/"
  },
  {
   "rank": 12,
   "holding": "Ascendis Pharma A/S",
   "ticker": null,
   "weight_pct": 2.114,
   "page": null
  },
  {
   "rank": 13,
   "holding": "Edwards Lifesciences Corp",
   "ticker": "EW",
   "weight_pct": 2.11,
   "page": "https://etfiq.com/holdings/ew/"
  },
  {
   "rank": 14,
   "holding": "Moderna Inc",
   "ticker": "MRNA",
   "weight_pct": 2.105,
   "page": "https://etfiq.com/holdings/mrna/"
  },
  {
   "rank": 15,
   "holding": "Kymera Therapeutics Inc",
   "ticker": "KYMR",
   "weight_pct": 1.987,
   "page": "https://etfiq.com/holdings/kymr/"
  },
  {
   "rank": 16,
   "holding": "Xenon Pharmaceuticals Inc",
   "ticker": "XENE",
   "weight_pct": 1.919,
   "page": null
  },
  {
   "rank": 17,
   "holding": "HeartFlow Inc",
   "ticker": "HTFL",
   "weight_pct": 1.89,
   "page": null
  },
  {
   "rank": 18,
   "holding": "Sartorius Stedim Biotech",
   "ticker": null,
   "weight_pct": 1.842,
   "page": "https://etfiq.com/holdings/dim/"
  },
  {
   "rank": 19,
   "holding": "Insmed Inc",
   "ticker": "INSM",
   "weight_pct": 1.794,
   "page": "https://etfiq.com/holdings/insm/"
  },
  {
   "rank": 20,
   "holding": "Veeva Systems Inc",
   "ticker": "VEEV",
   "weight_pct": 1.782,
   "page": "https://etfiq.com/holdings/veev/"
  },
  {
   "rank": 21,
   "holding": "Vaxcyte Inc",
   "ticker": "PCVX",
   "weight_pct": 1.765,
   "page": "https://etfiq.com/holdings/pcvx/"
  },
  {
   "rank": 22,
   "holding": "Revolution Medicines Inc",
   "ticker": "RVMD",
   "weight_pct": 1.731,
   "page": "https://etfiq.com/holdings/rvmd/"
  },
  {
   "rank": 23,
   "holding": "Caris Life Sciences Inc",
   "ticker": "CAI",
   "weight_pct": 1.713,
   "page": null
  },
  {
   "rank": 24,
   "holding": "Crinetics Pharmaceuticals Inc",
   "ticker": "CRNX",
   "weight_pct": 1.648,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Axsome Therapeutics Inc",
   "ticker": "AXSM",
   "weight_pct": 1.575,
   "page": "https://etfiq.com/holdings/axsm/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": 0.269
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/fmed/holdings/fmed-holdings.csv",
 "json_book": "https://etfiq.com/data/books/fmed.json",
 "markdown": "https://etfiq.com/funds/fmed/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of FMED, data as of May 31, 2026. https://etfiq.com/funds/fmed/holdings/"
}